Table 2

Percentage concordance with treatment phase occlusion regimen. No objective record available for subject AC during week 1 (see text)

SubjectWeek 1Week 2Week 3Week 4Average
SM101102998898
TL116114146133127
AC86769586
AI10493958995
DB9088828286
OS8263888680
RK6687829282
JS6043456553